CYPH (Cypherpunk Technologies) Total Operating Expense: $25.65 Mil (TTM As of Mar. 2026)


CYPH Cypherpunk Technologies Inc CYPH
28 GF Score
Price $0.67
! 3 Warning Signs
View Full Analysis

What is Cypherpunk Technologies Total Operating Expense?

Cypherpunk Technologies CYPH +2.45% 28 Total Operating Expense is $25.65 Mil as of Mar. 2026. GuruFocus rates CYPH with a GF Score™ of 28/100. The stock has 3 warning signs investors should review.

Cypherpunk Technologies's Total Operating Expense for the three months ended in Mar. 2026 was $4.82 Mil. Cypherpunk Technologies's Total Operating Expense for the trailing twelve months (TTM) ended in Mar. 2026 was $25.65 Mil.

Cypherpunk Technologies Total Operating Expense Related Terms

Cypherpunk Technologies Total Operating Expense Historical Data

* Premium members only.

The historical data trend for Cypherpunk Technologies's Total Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cypherpunk Technologies Total Operating Expense Chart

Cypherpunk Technologies Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Operating Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 41.70 54.71 85.94 70.06 36.70

Cypherpunk Technologies Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 15.86 12.35 3.22 5.26 4.82
CYPH
28GF Score
Cypherpunk Technologies Inc CYPH
Total Operating Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Cypherpunk Technologies Total Operating Expense Calculation

Total Operating Expense is the primary recurring expense associated with central operations that are incurred in order to generate sales.


Total Operating Expense for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $25.65 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Total Operating Expense of $25.65 Mil mean?
Cypherpunk Technologies (CYPH) has a Total Operating Expense of $25.65 Mil as of Mar. 2026. Total operating expense is the primary recurring expense associated with central operations. View historical data on Cypherpunk Technologies and its competitors.
Is Cypherpunk Technologies' Total Operating Expense too high?
Cypherpunk Technologies' current Total Operating Expense is $25.65 Mil. Overall, Cypherpunk Technologies has a GF Score™ of 28/100, reflecting its overall financial health beyond just this single metric.
How does Cypherpunk Technologies' Total Operating Expense compare to VLT and PGZ?
Cypherpunk Technologies' Total Operating Expense of $25.65 Mil can be compared against companies in the Asset Management industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Operating Expense for an Asset Management company?
A good Total Operating Expense depends on the Asset Management industry context. However, Total Operating Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Operating Expense mean?
A high Total Operating Expense can signal that a stock is expensive relative to its fundamentals. Total operating expense is the primary recurring expense associated with central operations. View historical data on Cypherpunk Technologies and its competitors. Cypherpunk Technologies's current Total Operating Expense is $25.65 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cypherpunk Technologies stock overvalued right now?
Cypherpunk Technologies (CYPH) has a current Total Operating Expense of $25.65 Mil. The current Total Operating Expense is $25.65 Mil. Cypherpunk Technologies' overall GF Score™ is 28/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Operating Expense calculated?
Total Operating Expense is calculated from a company's financial statements. For Cypherpunk Technologies (CYPH), the current Total Operating Expense is $25.65 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Cypherpunk Technologies Business Description

Other Exchanges 5MC:Germany
Address 47 Thorndike Street, Suite B1-1, Cambridge, MA, USA, 02141
Cypherpunk Technologies Inc is a privacy technology company focused on implementing a digital asset treasury business anchored by Zcash, which is a cryptographic digital asset that operates on a decentralized, open-source blockchain network known as the Zcash Network. Through its subsidiary, the company is also engaged in developing novel therapies for patients with cancer. The group holds Zcash as part of its digital treasury business and has the following drug candidates under development in its biopharma business: Sirexatamab (DKN-01), a monoclonal antibody that inhibits Dickkopf-related protein 1, or DKK1; and a preclinical antibody program, FL-501, that is designed to treat cachexia-related indications.
28GF Score

Get the complete analysis for CYPH

Total Operating Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.67
Price